You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 3, March 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Humanities
 •History of Medicine
 •Dermatology, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

Topical Hydrocortisone From Prescription to Over-the-Counter Sale

A Past Controversy: A Cautionary Tale

Scott Michael Ravis, MD; William H. Eaglstein, MD

Arch Dermatol. 2007;143(3):413-415.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It has been 25 years since topical hydrocortisone was approved for over-the-counter (OTC) sale to the public and 40 years since the American Academy of Dermatology's first committee to evaluate the proposal rejected OTC hydrocortisone as being too risky and hazardous for the public. Whenever a regulatory issue related to dermatology is likely to have an impact on the public at large, the need for organized dermatology to adopt a position, the mechanisms of so doing, and the likelihood of the position being proven correct over time remain the same. With that in mind, we review an issue that generated considerable controversy in its time and on which, in hindsight, organized dermatology proved to be on the wrong side.

Topical hydrocortisone cream was first found to be an effective therapy in 1952 when Sulzberger and Witten1 used it to treat eczematous dermatitis. . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED LETTERS

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone
Kalman L. Watsky and Erin M. Warshaw
Arch Dermatol. 2007;143(9):1217.
EXTRACT | FULL TEXT  

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone—Reply
William H. Eaglstein and Scott M. Ravis
Arch Dermatol. 2007;143(9):1217-1218.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diamonds are forever: the cortisone legacy
Hillier
J Endocrinol 2007;195:1-6.
ABSTRACT | FULL TEXT  

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone
Watsky and Warshaw
Arch Dermatol 2007;143:1217-1217.
FULL TEXT  

Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone Reply
Eaglstein and Ravis
Arch Dermatol 2007;143:1217-1218.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.